Loading...
Loading...
Pfizer
PFE is expected to raise its bid for AstraZeneca
AZN, and has not ruled out a hostile offer for the UK pharma company, according to sources reported by
Financial Times. Sources close to the companies say Pfizer is like to improve on its £50/share offer.
View full article http://www.ft.com/intl/cms/s/0/1c871ef2-dea5-11e3-9640-00144feabdc0.html?siteedition=intl#axzz325YiniBB
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in